Applied biotechnology for production of immunoglobulin Y specific to hepatitis A virus

Journal of Virological Methods

Volumn 171, Issue 1, 2011, Pages 102-106

  de Paula, Vanessa Salete ^a   da Silva, Alexandre dos Santos ^a   de Vasconcelos, Gentil Arthur Lins Bentes Mendonça ^a   Iff, Ezio Tavares ^b   Monteiro Silva, Maria Eduarda ^b   Kappel, Livia Abud ^a,b   Cruz, Paula Borba ^a   Pinto, Marcelo Alves ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Departamento de Zoologia   (Brazil)

Author keywords

Alum adjuvant; CpG ODN; Hepatitis A virus; Immunoglobulin Y (IgY); Incomplete Freund's adjuvant

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; FREUND ADJUVANT; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN Y; IMMUNOGLOBULIN Y ANTIBODY; MACROGOL 6000; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; YOLK PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BIOTECHNOLOGY; BLOOD ANALYSIS; CELL CULTURE; CONTROLLED STUDY; EGG YOLK; ENZYME LINKED IMMUNOSORBENT ASSAY; HEN; HEPATITIS A VIRUS; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; INOCULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION; VIRUS NEUTRALIZATION; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOTECHNOLOGY; BLOTTING, WESTERN; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HEPATITIS A VIRUS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULINS; OVUM; VACCINATION;

AVES; HEPATITIS A VIRUS;

EID: 78650525192     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.10.008     Document Type: Article

References (32)

1. Cova L. DNA-designed avian IgY antibodies: novel tools for research, diagnostics and therapy. J. Clin. Virol. 2005, 34(Suppl. 1):S70-74.
2. Davis H.L., Weeratna R., Waldschmidt T.J., Tygrett L., Schorr J., Krieg A.M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 1998, 160:870-876.
3. de Paula V.S., Perse A.S., Amado L.A., de Morais L.M., de Lima S.M., Tourinho R.S., Gaspar A.M., Pinto M.A. Kinetics of hepatitis A virus replication in vivo and in vitro using negative-strand quantitative PCR. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:1167-1176.
4. Devi C.M., Bai M.V., Lal A.V., Umashankar P.R., Krishnan L.K. An improved method for isolation of anti-viper venom antibodies from chicken egg yolk. J. Biochem. Biophys. Methods 2002, 51:129-138.
5. Eastcott J.W., Holmberg C.J., Dewhirst F.E., Esch T.R., Smith D.J., Taubman M.A. Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid. Vaccine 2001, 19:1636-1642.
6. Ferwerda G., Netea M.G., Joosten L.A., van der Meer J.W., Romani L., Kullberg B.J. The role of Toll-like receptors and C-type lectins for vaccination against Candida albicans. Vaccine 2010, 28:614-622.
7. Garlapati S., Facci M., Polewicz M., Strom S., Babiuk L.A., Mutwiri G., Hancock R.E., Elliott M.R., Gerdts V. Strategies to link innate and adaptive immunity when designing vaccine adjuvants. Vet. Immunol. Immunopathol. 2009, 128:184-191.
8. Gaspar A.M., Vitral C.L., Yoshida C.F., Schatzmayr H.G. Fast growth of a Brazilian hepatitis A virus (HAF-203) in a primate cell line. Braz. J. Med. Biol. Res. 1993, 26:203-206.
9. Heeg K., Dalpke A., Peter M., Zimmermann S. Structural requirements for uptake and recognition of CpG oligonucleotides. Int. J. Med. Microbiol. 2008, 298:33-38.
10. Hendrickx G., Van Herck K., Vorsters A., Wiersma S., Shapiro C., Andrus J.K., Ropero A.M., Shouval D., Ward W., Van Damme P. Has the time come to control hepatitis A globally? Matching prevention to the changing epidemiology. J. Viral Hepat. 2008, 15(Suppl. 2):1-15.
11. Hollinger F.B., Emerson S.U. Hepatitis A virus. Fields Virology 2001, vol. I:799-840. Lippincott Williams & Wilkins, New York, NY.
12. Hutin Y.J., Pool V., Cramer E.H., Nainan O.V., Weth J., Williams I.T., Goldstein S.T., Gensheimer K.F., Bell B.P., Shapiro C.N., Alter M.J., Margolis H.S. A multistate, foodborne outbreak of hepatitis A. National Hepatitis A Investigation Team. N. Engl. J. Med. 1999, 340:595-602.
13. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995, 374:546-549.
14. Leslie G.A., Clem L.W. Phylogen of immunoglobulin structure and function. 3. Immunoglobulins of the chicken. J. Exp. Med. 1969, 130:1337-1352.
15. Levesque S., Martinez G., Fairbrother J.M. Improvement of adjuvant systems to obtain a cost-effective production of high levels of specific IgY. Poult. Sci. 2007, 86:630-635.
16. Li X., Nakano T., Sunwoo H.H., Paek B.H., Chae H.S., Sim J.S. Effects of egg and yolk weights on yolk antibody (IgY) production in laying hens. Poult. Sci. 1998, 77:266-270.
17. Loeken M.R., Roth T.F. Analysis of maternal IgG subpopulations which are transported into the chicken oocyte. Immunology 1983, 49:21-28.
18. Mahmood M.S., Siddique M., Hussain I., Khan A., Mansoor M.K. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in hens adjuvanted with CpG oligodeoxynucleotide. Vaccine 2006, 24:4838-4846.
19. Mine Y., Kovacs-Nolan J. Chicken egg yolk antibodies as therapeutics in enteric infectious disease: a review. J. Med. Food 2002, 5:159-169.
20. Moldoveanu Z., Love-Homan L., Huang W.Q., Krieg A.M. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine 1998, 16:1216-1224.
21. Narat M. Productions of antibodies in chickens. Food Technol. Biotechnol. 2003, 41:259-267.
22. Patterson R., Youngner J.S., Weigle W.O., Dixon F.J. Antibody production and transfer to egg yolk in hens. J. Immunol. 1962, 89:272-278.
23. Pauly D., Dorner M., Zhang X., Hlinak A., Dorner B., Schade R. Monitoring of laying capacity, immunoglobulin Y concentration, and antibody titer development in hens immunized with ricin and botulinum toxins over a two-year period. Poult. Sci. 2009, 88:281-290.
24. Polson A., von Wechmar M.B., van Regenmortel M.H. Isolation of viral IgY antibodies from yolks of immunized hens. Immunol. Commun. 1980, 9:475-493.
25. Polson A., Coetzer T., Kruger J., von Maltzahn E., van der Merwe K. Improvements in the isolation of IgY from the yolks of eggs laid by immunized hens. J. Immunol. Invest. 1985, 14:323-327.
26. Schade R., Burger W., Schoneberg T., Schniering A., Schwarzkopf C., Hlinak A., Kobilke H. Avian egg yolk antibodies. The egg laying capacity of hens following immunisation with antigens of different kind and origin and the efficiency of egg yolk antibodies in comparison to mammalian antibodies. Altex 1994, 11:75-84.
27. Shimizu M., Fitzsimmons R.C., Nakai S. Anti-E. coli immunoglobulin Y isolated from egg yolk of immunized hens as a potential food ingredient. J. Food Sci. 1988, 53:7.
28. Sunwoo H.H., Nakano T., Dixon W.T., Sim J.S. Immune responses in hens against lipopolysaccharide of Escherichia coli and Salmonella typhimurium. Poult. Sci. 1996, 75:342-345.
29. Tsuji S., Matsumoto M., Takeuchi O., Akira S., Azuma I., Hayashi A., Toyoshima K., Seya T. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors. Infect. Immun. 2000, 68:6883-6890.
30. Vincent I.E., Lucifora J., Durantel D., Hantz O., Chemin I., Zoulim F., Trepo C. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro. Antivir. Ther. 2009, 14:131-135.
31. Vleugels B., Ververken C., Goddeeris B.M. Stimulatory effect of CpG sequences on humoral response in hens. Poult. Sci. 2002, 81:1317-1321.
32. Wang Y., Shan C., Ming S., Liu Y., Du Y., Jiang G. Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken. Res. Vet. Sci. 2009, 86:399-405.